These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 8645511)

  • 1. [Comparison of 2 treatment strategies with prednisone and interferon in chronic hepatitis B].
    Gómez Camacho F; Poyato González A; Vignote Alguacil ML; de La Mata García M; González Fernández RA; López Rubio F; Marchal Molina T; Miño Fugarolas G
    Rev Esp Enferm Dig; 1996 Mar; 88(3):185-90. PubMed ID: 8645511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effect of interferon alpha alone or after prednisone withdrawal in chronic hepatitis B. Interim report and review of the literature.
    Gonzalez-Mateos F; Garcia-Monzon C; Garcia-Buey L; Garcia-Sanchez A; Pajares JM; Moreno-Otero R
    Hepatogastroenterology; 1995; 42(6):893-9. PubMed ID: 8847042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic efficacy of sequential and simultaneous treatments with interferon-alpha and lamivudine in children with chronic hepatitis B.
    Akman SA; Okcu SC; Halicioğlu O; Sutcuoglu S; Anil M; Kizilgunesler A; Bakiler AR
    Pediatr Int; 2007 Dec; 49(6):848-52. PubMed ID: 18045284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant interferon-alpha-2A with or without steroid pretreatment in children with chronic hepatitis B.
    Ozen H; Koçak N; Gürakan F; Yüce A
    Turk J Pediatr; 1998; 40(4):503-14. PubMed ID: 10028858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant alpha 2 interferon with or without prednisone in Chinese HBsAg carrier children.
    Lai CL; Lin HJ; Lau JN; Flok AS; Wu PC; Chung HT; Wong LK; Leung MP; Yeung CY
    Q J Med; 1991 Feb; 78(286):155-63. PubMed ID: 2031078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment with lamivudine and interferon monotherapies in patients with chronic hepatitis B not responding to interferon alone: results of a pilot study.
    Serfaty L; Thabut D; Zoulim F; Andreani T; Chazouillères O; Carbonell N; Loria A; Poupon R
    Hepatology; 2001 Sep; 34(3):573-7. PubMed ID: 11526544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon and steroid treatment in patients with chronic hepatitis C and antinuclear or anti-liver-kidney microsomal antibodies.
    Provenzano G; Almasio P; Fabiano C; Magrin S; Pinzello G; Vaccaro A; Craxì A
    Ital J Gastroenterol; 1996 Sep; 28(7):377-80. PubMed ID: 8937938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of alpha interferon for the treatment of chronic hepatitis B infection in Christchurch.
    Burt MJ; Ross AG; Schroeder BA; Chambers ST; Chapman BA
    N Z Med J; 1996 May; 109(1021):162-4. PubMed ID: 8657367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T; Shiraki K; Inoue H; Okano H; Deguchi M; Sugimoto K; Ohmori S; Murata K; Nakano T
    Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of lamivudine and interferon-alpha combination therapy versus interferon-alpha monotherapy for the treatment of HBeAg-negative chronic hepatitis B patients: a randomized clinical trial.
    Karabay O; Tamer A; Tahtaci M; Vardi S; Celebi H
    J Microbiol Immunol Infect; 2005 Aug; 38(4):262-6. PubMed ID: 16118673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy effect of lamivudine combination with alpha interferon on patients with chronic hepatitis B].
    Deng H; Zhao ZX; Xu QH; Zhou YP; Chen YM; Yao JL
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):305-8. PubMed ID: 12773249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of two treatment schedules with different doses of interferon in chronic HBsAg+ anti-HBe+ hepatitis].
    Facciorusso D; Giacobbe A
    Recenti Prog Med; 1996 Jan; 87(1):12-5. PubMed ID: 8711248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.
    Utili R; Sagnelli E; Gaeta GB; Galanti B; Nardiello S; Felaco FM; Pasquale G; Marrone A; Aprea L; Pizzella T
    J Hepatol; 1994 Feb; 20(2):163-7. PubMed ID: 8006395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of polyarteritis nodosa and Churg-Strauss syndrome: indications of plasma exchanges.
    Guillevin L; Lhote F
    Transfus Sci; 1994 Dec; 15(4):371-88. PubMed ID: 10155556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.